Absinth, also known as Artemisia absinthium, is a species of wormwood native to temperate regions of Europe, Asia and northern Africa. It grows naturally on uncultivated, arid ground, on rocky slopes and wastelands and it can also be cultivated in dry soil. The time of harvesting is important for the quality and the composition of the constituents. Metabolism processes change over the flowering period and ripening of the fruit. During the flowering period the concentration of bitter constituents increases. The main traditional indications for absinth include lack of appetite, dyspeptic complaints such as minor gastrointestinal spasms, repletion, flatulence, and spasmodic functional disorders of the biliary tract. Absinth formulations are available as an herbal substance for tea preparation, powdered herbal substance, expressed juice and tincture. Other traditional uses attributed to absinth include as an aromatic bitter, bitter tonic, anthelmintic, stomachic, antiparasitic, insecticide, antiseptic, choleretic, carminative, antiinflammatory, and mild antidepressant.
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.
Please note: Due to the complexity and amount of studies regarding this compound—a Natural Health Product—increased cost is charged.
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:
To order an OEL/ADE monograph for Absinth, just click the ADD TO CART button.
If you're wondering about HBEL, we have something for you.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’ OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.